Research shows that GLP-1 medications can extend active weight loss to around 24 months before plateauing, compared to roughly 12 months with calorie restriction alone, because they reduce compensatory hunger signals that normally halt progress
We are starting to better understand the mechanism at the brain level as to how these medications work
Additionally, Baumeier et al
Challenges in GLP-1 Medication Usage Despite the emerging therapeutic benefits of GLP-1 medications, these treatments also face several challenges, including: Patient Compliance Due to Side Effects One considerable challenge of GLP-1 treatments is their administration method, which is typically a daily injection
Either way, it is a solution that feels natural because it works with your own biology
Treatment of animals with excessive -amyloidosis with newly developed reversible MAO-B inhibitor KDS2010 or the potent H 2 O 2 scavenger AAD-2004 ameliorated neurodegeneration